Prevalence and predictors of depression, anxiety, and stress among recovered COVID-19 patients in Vietnam

• Autorzy: Trang L.T.T , Le C.N. , Chutipatana N. , Shohaimi S. , Suwanbamrung C.
• Języki publikacji: EN

Abstrakty

EN

Background. During the COVID-19 pandemic, a high prevalence of mental health distress has been reported among people who have recovered from the disease. Objectives. To assess the prevalence of depression, anxiety, and stress as well as identify predictors among recovered COVID-19 patients after more than six months of being discharged in Dong Thap Province, Vietnam. Material and methods. The cross-sectional study was conducted among 549 eligible participants recruited by stratified sampling. Data was collected using the depression, anxiety and stress scale – 21 items had Content Validity Index = 0.9, and Cronbach’s alpha for depression, anxiety and stress sub-scales were 0.95, 0.81, and 0.86, respectively. Descriptive statistics were used to measure the prevalence levels and distribution of characteristics of the participant, while factors influencing depression, anxiety, and stress were predicted using binary logistic regression. Results. The overall prevalence of depression, anxiety, and stress were 24.8% (95% CI: 21.2-28.6), 41.5% (95% CI: 37.4- 45.8), and 25.3% (95% CI: 21.7-29.2), respectively. The predictors of depression were living in urban area (OR = 1.97; 95% CI: 1.27-3.08), holding a bachelor’s degree (OR:3.51; 95% CI: 1.13-10.8), having a high monthly income (OR: 2.57; 95% CI: 1.03-6.38), diabetes (OR: 2.21; 95% CI: 1.04-4.68), heart disease (OR: 3.83; 95% CI: 1.79-8.17), respiratory disease (OR: 3.49; 95% CI: 1.24-9.84), and diarrhea (OR: 4.07; 95% CI: 1.06-15.6). Living in the urban area (OR: 1.57; 95% CI: 1.07-2.29), having sleep disturbance (OR: 2.32; 95% CI: 1.56-3.46), and fatigue (OR: 1.57; 95% CI: 1.03-2.39) were predictors for anxiety. Having respiratory disease (OR: 3.75; 95% CI: 1.47-9.60) or diarrhea (OR: 4.34; 95% CI: 1.18-15.9) were predictors of stress. Conclusion. People who have recovered from COVID-19 should be assessed for symptoms of depression, anxiety, and stress. Primary healthcare providers should develop interventions to support their recovery.

• Wydawca: -
• Czasopismo: Roczniki Państwowego Zakładu Higieny
• Rocznik: 2023
• Tom: 74
• Numer: 2
• Opis fizyczny: p.217-230,fig.,ref.

Twórcy

autor

Trang L.T.T

• Master of Public Health Program in Public Health Research, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand
• Faculty of Basic Science and Public Health, Dong Thap Medical College, Dong Thap, Vietnam

autor

Le C.N.

• Master of Public Health Program in Public Health Research, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand
• Excellent Center for Dengue and Community Public Health (EC for DACH), School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand

autor

Chutipatana N.

• Master of Public Health Program in Public Health Research, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand
• Excellent Center for Dengue and Community Public Health (EC for DACH), School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand

autor

Shohaimi S.

• Department of Biology, Faculty of Science, University Putra Malaysia, Malaysia

autor

Suwanbamrung C.

• Master of Public Health Program in Public Health Research, Excellent Center for Dengue and Community Public Health (EC for DACH), School of Public Health, Walailak University, Thasala District, Nakhon Si Thammarat Province +6680160, Thailand
• Excellent Center for Dengue and Community Public Health (EC for DACH), School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand

Bibliografia

• 1. American Psychological Association: Anxiety (2017). Available https://www.apa.org/topics/anxiety (Accessed 15 May 2022)
• 2. American Psychological Association: Depression (2019). Available https://www.apa.org/topics/depression (Accessed 15 May 2022)
• 3. American Psychological Association: What’s the difference between stress and anxiety? (2022). Available https://www.apa.org/topics/stress/anxietydifference#:~:text=People%20under%20stress%20experience%20mental,the%20absence%20of%20a%20stressor. (Accessed 02 June 2022)
• 4. Arsenault-Lapierre G., Kim C., and Turecki G.: Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 2004;4(1). 1-11. doi: 10.1186/1471-244X-4-37.
• 5. Bareket-Bojmel L., Shahar G., and Margalit M.: COVID-19-related economic anxiety is as high as health anxiety: findings from the USA, the UK, and Israel. International Journal of Cognitive Therapy 2021;14(3):566-574. doi: 10.1007/s41811-020-00078-3.
• 6. Bourmistrova N.W., Solomon T., Braude P., Strawbridge R., and Carter B.: Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord 2022;299:118-125. doi: 10.1016/j.jad.2021.11.031.
• 7. Brådvik L.: Suicide Risk and Mental Disorders. Int J Environ Res Public Health 2018; 15(9). doi: 10.3390/ijerph15092028.
• 8. Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., Lin K., Mansur R.B., Ho R.C., Rosenblat J.D., Miskowiak K.W., Vinberg M., Maletic V., and McIntyre R.S.: Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022;101:93-135. doi: 10.1016/j.bbi.2021.12.020.
• 9. Crawford J.R. and Henry J.D.: The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003;42(Pt 2):111-31. doi: 10.1348/014466503321903544.
• 10. DeJean D., Giacomini M., Vanstone M., and Brundisini F.: Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser 2013;13(16):1-33.
• 11. Do Duy C., Nong V.M., Van A.N., Thu T.D., Do Thu N., and Quang T.N.: COVID‐19‐related stigma and its association with the mental health of health‐care workers after quarantine in Vietnam. Psychiatry and Clinical Neurosciences 2020;74(10):566. doi: 10.1111/pcn.13120.
• 12. Doan Q.H., Tran N.N., Than M.H., Nguyen H.T., Bui V.S., Nguyen D.H., Vo H.L., Do T.T., Pham N.T., Nguyen T.K., Cao D.C., Nguyen V.T., Tran T.T., Pham B.H., Tran A.L., Nguyen V.T., Nguyen V.T., Tran X.T., Lai D.T., Vu Q.H., and Otsu S.: Depression, Anxiety and Associated Factors among Frontline Hospital Healthcare Workers in the Fourth Wave of COVID-19: Empirical Findings from Vietnam. Trop Med Infect Dis 2021;7(1). doi: 10.3390/tropicalmed7010003.
• 13. Duong K.N.C., Le Bao T.N., Nguyen P.T.L., Van T.V., Lam T.P., Gia A.P., Anuratpanich L., and Van B.V.: Psychological Impacts of COVID-19 During the First Nationwide Lockdown in Vietnam: a Web-Based, Cross-Sectional Survey Study. JMIR formative research 2020;4(12). e24776. doi: 10.2196/24776.
• 14. Edouard Mathieu H.R., Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina and Max Roser: Coronavirus Pandemic (COVID-19) (2020). Available https://ourworldindata. org/coronavirus (Accessed 31 December 2022).
• 15. Gramaglia C., Gambaro E., Bellan M., Balbo P.E., Baricich A., Sainaghi P.P., Pirisi M., Baldon G., Battistini S., Binda V., Feggi A., Gai M., Gattoni E., Jona A., Lorenzini L., Marangon D., Martelli M., Prosperini P., and Zeppegno P.: Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients. Front Psychiatry 2021;12.667385. doi: 10.3389/fpsyt.2021.667385.
• 16. Hao F., Tam W., Hu X., Tan W., Jiang L., Jiang X., Zhang L., Zhao X., Zou Y., Hu Y., Luo X., McIntyre R.S., Quek T., Tran B.X., Zhang Z., Pham H.Q., Ho C.S.H., and Ho R.C.M.: A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities. Transl Psychiatry 2020;10(1):355. doi: 10.1038/s41398-020-01039-2.
• 17. Henry J.D. and Crawford J.R.: The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large nonclinical sample. Br J Clin Psychol 2005;44(Pt 2):227-39. doi: 10.1348/014466505x29657.
• 18. Islam M.S., Ferdous M.Z., Islam U.S., Mosaddek A.S.M., Potenza M.N., and Pardhan S.: Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh. International Journal of Environmental Research and Public Health 2021;18(4):1453. doi: 10.3390/ijerph18041453.
• 19. Islam M.S., Sujan M.S.H., Tasnim R., Sikder M.T., Potenza M.N., and van Os J.: Psychological responses during the COVID-19 outbreak among university students in Bangladesh. PLoS One 2020;15(12). e0245083. doi: 10.1371/journal.pone.0245083.
• 20. Kotrlik J. and Higgins C.: Organizational research: Determining the appropriate sample size in survey research. Information technology, learning, and performance journal 2001;19(1):43.
• 21. Le H.T., Lai A.J.X., Sun J., Hoang M.T., Vu L.G., Pham H.Q., Nguyen T.H., Tran B.X., Latkin C.A., Le X.T.T., Nguyen T.T., Pham Q.T., Ta N.T.K., Nguyen Q.T., Ho R.C.M., and Ho C.S.H.: Anxiety and Depression Among People Under the Nationwide Partial Lockdown in Vietnam. Front Public Health 2020;8:589359. doi: 10.3389/fpubh.2020.589359.
• 22. Le M.T.H., Tran T.D., Holton S., Nguyen H.T., Wolfe R., and Fisher J.: Reliability, convergent validity and factor structure of the DASS-21 in a sample of Vietnamese adolescents. PLoS One 2017;12(7):e0180557. doi: 10.1371/journal.pone.0180557.
• 23. Li W., Zhang H., Zhang C., Luo J., Wang H., Wu H., Zhu Y., Cui H., Wang J., Li H., Zhu Z., Xu Y., and Li C.: The Prevalence of Psychological Status During the COVID-19 Epidemic in China: A Systemic Review and Meta-Analysis. Frontiers in Psychology 2021;12. doi: 10.3389/fpsyg.2021.614964.
• 24. Liu D., Baumeister R.F., Veilleux J.C., Chen C., Liu W., Yue Y., and Zhang S.: Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Research 2020; 292. 113297. doi: 10.1016/j.psychres.2020.113297.
• 25. Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., and Villapol S.: More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific reports 2021;11(1):1-12. doi: 10.1038/s41598-021-95565-8.
• 26. Lovibond S.H. and Lovibond P.F., Manual for the Depression Anxiety Stress Scales. 1996: Psychology Foundation of Australia.
• 27. Mattioli F., Stampatori C., Righetti F., Sala E., Tomasi C., and De Palma G.: Neurological and cognitive sequelae of Covid-19: a four-month follow-up. J Neurology 2021;268(12). 4422-4428. doi: 10.1007/s00415-021-10579-6.
• 28. Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., and Rovere-Querini P.: Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity 2020;89:594-600. doi: 10.1016/j.bbi.2020.07.037.
• 29. MedlinePlus: Anxiety (2020). Available https://medlineplus.gov/anxiety.html (Accessed 22 Feb 2022)
• 30. MedlinePlus: Stress and your health (2020). Available ht tps://medl ineplus.gov/ency/ar t icle/003211.htm#:~:text=St ress%20is%20a%20feeling%20of,danger%20or%20meet%20a%20deadline (Accessed 22 Feb 2022)
• 31. Méndez R., Balanzá‐Martínez V., Luperdi S.C., Estrada I., Latorre A., González‐Jiménez P., Bouzas L., Yépez K., Ferrando A., and Reyes S.: Long‐term neuropsychiatric outcomes in COVID‐19 survivors: A 1‐year longitudinal study. J Int. Medicine 2022; 291(2). 247-251.
• 32. Morin L., Savale L., Pham T., Colle R., Figueiredo S., Harrois A., Gasnier M., Lecoq A.-L., Meyrignac O., and Noel N.: Four-month clinical status of a cohort of patients after hospitalization for COVID-19. Jama 2021; 325(15). 1525-1534. doi: 10.1001/jama.2021.3331.
• 33. National Institutes of Mental Health: Depression (2021). Available https://www.nimh.nih.gov/health/publications/depression (Accessed 2022 22 Feb)
• 34. National Institutes of Mental Health: I’m So Stressed Out! Fact Sheet (2021). Available https://www.nimh.nih.gov/health/publications/so-stressed-out-factsheet#part_6631 (Accessed 22 Feb 2022)
• 35. Özdin S. and Bayrak Özdin Ş.: Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry 2020; 66(5). 504-511. doi: 10.1177/0020764020927051.
• 36. Pei H., Wu Q., Xie Y., Deng J., Jiang L., and Gan X.: A Qualitative Investigation of the Psychological Experiences of COVID-19 Patients Receiving Inpatient Care in Isolation. Clinical Nursing Research 2021; 30(7). 1113-1120. doi: 10.1177/10547738211024807.
• 37. Prakash J., Dangi A., Chaterjee K., Yadav P., Srivastava K., and Chauhan V.S.: Assessment of depression, anxiety and stress in COVID-19 infected individuals and their families. Med J Armed Forces India 2021; 77. S424-S429. doi: 10.1016/j.mjafi.2021.06.013.
• 38. Rass V., Beer R., Schiefecker A.J., Kofler M., Lindner A., Mahlknecht P., Heim B., Limmert V., Sahanic S., and Pizzini A.: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study. European Journal ofNneurology 2021; 28(10). 3348-3359. doi: 10.1111/ene.14803.
• 39. Renaud-Charest O., Lui L.M.W., Eskander S., Ceban F., Ho R., Di Vincenzo J.D., Rosenblat J.D., Lee Y., Subramaniapillai M., and McIntyre R.S.: Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res 2021;144:129-137. doi: 10.1016/j.jpsychires.2021.09.054.
• 40. Robins E., Murphy G.E., Wilkinson Jr R.H., Gassner S., and Kayes J.: Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. American Journal of Public Health and the Nations Health 1959;49(7):888-899.
• 41. Shi L., Lu Z.-A., Que J.-Y., Huang X.-L., Liu L., Ran M.-S., Gong Y.-M., Yuan K., Yan W., Sun Y.-K., Shi J., Bao Y.-P., and Lu L.: Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic. JAMA Network Open 2020;3(7).e2014053-e2014053. doi: 10.1001/jamanetworkopen.2020.14053.
• 42. Srivastava A., Bala R., Devi T.P., and Anal L.: Psychological trauma and depression in recovered COVID-19 patients: A telecommunication-based observational study. Trends Psychiatry Psychother 2021. doi: 10.47626/2237-6089-2021-0381.
• 43. Tran B.X., Nguyen H.T., Le H.T., Latkin C.A., Pham H.Q., Vu L.G., Le X.T.T., Nguyen T.T., Pham Q.T., Ta N.T.K., Nguyen Q.T., Ho C.S.H., and Ho R.C.M.: Impact of COVID-19 on Economic Well-Being and Quality of Life of the Vietnamese During the National Social Distancing. Frontiers in Psychology 2020; 11. doi: 10.3389/fpsyg.2020.565153.
• 44. Tran T.D., Tran T., and Fisher J.: Validation of the depression anxiety stress scales (DASS) 21 as a screening instrument for depression and anxiety in a rural community-based cohort of northern Vietnamese women. BMC Psychiatry 2013;13:24. doi: 10.1186/1471- 244x-13-24.
• 45. Tuan N.Q., Phuong N.D., Co D.X., Son D.N., Chinh L.Q., Dung N.H., Thach P.T., Thai N.Q., Thu T.A., and Tuan N.A.: Prevalence and factors associated with psychological problems of the healthcare workforce in Vietnam: findings from COVID-19 hotspots in the national second wave. Healthcare 2021;9(6):718. doi: 10.3390/healthcare9060718.
• 46. Wang C., Chudzicka-Czupała A., Tee M.L., Núñez María I.L., Tripp C., Fardin M.A., Habib H.A., Tran B.X., Adamus K., Anlacan J., García M.E.A., Grabowski D., Hussain S., Hoang M.T., Hetnał M., Le X.T., Ma W., Pham H.Q., Reyes P.W.C., Shirazi M., Tan Y., Tee C.A., Xu L., Xu Z., Vu G.T., Zhou D., Chan N.A., Kuruchittham V., McIntyre R.S., Ho C.S.H., Ho R., and Sears S.F.: A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans. Scientific Reports 2021;11(1):6481. doi: 10.1038/s41598-021-85943-7.
• 47. Wang C., Pan R., Wan X., Tan Y., Xu L., Ho C.S., and Ho R.C.: Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health 2020;17(5). doi: 10.3390/ijerph17051729.
• 48. World Health Organization: Mental Health and COVID-19: Early evidence of the pandemic’s impact: Scientific brief, 2 March 2022 (2022). Available https://www.who.int/publications/i/item/WHO-2019-nCoVSci_Brief-Mental_health-2022.1 (Accessed 15 March 2022)
• 49. World Health Organization: Policy Brief: COVID-19 and the Need for Action on Mental Health (2020). Available (Accessed 13 May 2022)
• 50. World Health Organization: WHO Coronavirus (COVID-19) Dashboard (2022). Available https:// covid19.who.int/ (Accessed 31 December 2022)
• 51. Zanon C., Brenner R.E., Baptista M.N., Vogel D.L., Rubin M., Al-Darmaki F.R., Goncalves M., Heath P.J., Liao H.Y., Mackenzie C.S., Topkaya N., Wade N.G., and Zlati A.: Examining the Dimensionality, Reliability, and Invariance of the Depression, Anxiety, and Stress Scale-21 (DASS-21) Across Eight Countries. Assessment 2021;28(6):1531-1544. doi: 10.1177/1073191119887449.
• 52. Zhou F., Tao M., Shang L., Liu Y., Pan G., Jin Y., Wang L., Hu S., Li J., Zhang M., Fu Y., and Yang S.: Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis. Front Med (Lausanne) 2021;8:717194. doi: 10.3389/fmed.2021.717194.

Identyfikatory

DOI

10.32394/rpzh.2023.0261